Latest Breaking News On - Deneen vojta - Page 1 : comparemela.com

Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded
quicknews-africa.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from quicknews-africa.net Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSaudi arabiaLaura balanDeneen vojtaHikma pharmaceuticalsExecutive chairmanChief executive officerNorth africanVictoria hull

Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Result of AGM

Investegate announcements from Hikma Pharmaceutical, Result of AGM

United arab emiratesCity ofUnited kingdomMazen darwazahPatrick butlerJohn castellaniDeneen vojtaHussein arkhaghaLaura balanNina hendersonAli al husryNational storage mechanismRemuneration committeeGovernance committeeHikma pharmaceuticalsAudit committee

Hikma Pharmaceuticals (LON:HIK) Stock Rating Reaffirmed by Jefferies Financial Group

Hikma Pharmaceuticals (LON:HIK – Get Rating)‘s stock had its “buy” rating reaffirmed by analysts at Jefferies Financial Group in a research note issued to investors on Wednesday, Marketbeat reports. They currently have a GBX 2,080 ($25.76) target price on the stock. Jefferies Financial Group’s price target suggests a potential upside of 16.85% from the company’s […]

Deneen vojtaRoyal bankBerenberg bankHikma pharmaceuticals tradingHikma pharmaceuticalsJefferies financial groupNews ratings for hikma pharmaceuticals dailyAnalyst recommendations for hikma pharmaceuticalsJpmorgan chase coGet ratingFinancial groupHikma pharmaceuticals dailyLon hikReiterated ratingJefferies financial group inc

Hikma Pharmaceuticals (LON:HIK) Share Price Crosses Above 200-Day Moving Average of $1,533 47

Should You Buy or Sell Hikma Pharmaceuticals Stock? Get The Latest HIK Stock Forecast, Price Target, Dividend Info, and Headlines at MarketBeat.

Deneen vojtaHikma pharmaceuticalsBerenberg bankInsider transactions at hikma pharmaceuticalsNews ratings for hikma pharmaceuticals dailyRoyal bankJpmorgan chase coHikma pharmaceuticals increases dividendHikma pharmaceuticals stock performanceGet ratingHikma pharmaceuticals daily

Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) Price Target at GBX 1,882

Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) has earned an average rating of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among […]

Deneen vojtaJpmorgan chase coHikma pharmaceuticals increases dividendNews ratings for hikma pharmaceuticals dailyHikma pharmaceuticalsHikma pharmaceuticals stock downHikma pharmaceuticals company profileAnalyst recommendations for hikma pharmaceuticalsRoyal bankBerenberg bankGet ratingPharmaceuticals stock downHikma pharmaceuticals dailyLon hik